SEC Form 4 · accession 0000908662-16-000526
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathaniel S. Gardiner
Officer — Sr. VP & General Counsel
Period of report
May 11, 2016
Accepted (ET)
May 12, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2016 | P | 500 | $24.445 | A | 1,900 | D |
Table II — derivative securities
No Table II lines on this filing.